Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Pembrolizumab in mycosis fungoides and Sezary syndrome: Updated results of the CITN multicenter Phase 2 study Khodadoust, M. S., Rook, A. H., Porcu, P., Foss, F., Moskowitz, A., Shustov, A. R., Shanbhag, S., Sokol, L., Fling, S. P., Li, S., Fong, S., Kim, J., Yang, Y., Yearley, J., Subrahmanyam, P., Maecker, H., Horwitz, S. M., Sharon, E., Cheever, M. A., Kim, Y. H. ELSEVIER SCI LTD. 2018: S37
View details for DOI 10.1016/j.ejca.2018.07.304
View details for Web of Science ID 000443008600101